EVE Health Group Ltd
EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003… Read more
Market Cap & Net Worth: EVE Health Group Ltd (EVEDA)
EVE Health Group Ltd (AU:EVEDA) has a market capitalization of $224.22 (AU$362.12) as of March 18, 2026. Listed on the AU stock exchange, this Australia-based company holds position #19803 globally and #331 in its home market, demonstrating a 33.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EVE Health Group Ltd's stock price AU$0.04 by its total outstanding shares 9053 (9.05K).
EVE Health Group Ltd Market Cap History: 2025 to 2025
EVE Health Group Ltd's market capitalization history from 2025 to 2025. Data shows growth from $224.22 to $224.22 (0.00% CAGR).
EVE Health Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EVE Health Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of EVEDA by Market Capitalization
Companies near EVE Health Group Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to EVE Health Group Ltd by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
EVE Health Group Ltd Historical Marketcap From 2025 to 2025
Between 2025 and today, EVE Health Group Ltd's market cap moved from $224.22 to $ 224.22, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$224.22 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of EVE Health Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $224.22 USD |
| MoneyControl | $224.22 USD |
| MarketWatch | $224.22 USD |
| marketcap.company | $224.22 USD |
| Reuters | $224.22 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.